Heart Failure Flashcards
Definitions of heart failure diagnostic categories
HFrEF - EF < 40%
HFpEF - EF > 50% (delayed HR recovery and less increase in CO with exercise)
Subcategories
HFpEF, borderline - EF 41-49%
HFpEF, improved - pts with HFpEF who previously had HFrEF
What are the New York Heart Association (NYHA) Classifications
I - no limitation
II - comfortable at rest, but ordinary physical activity results in symptoms
III - comfortable at rest, but less than ordinary activity causes symptoms
IV - unable to carry out any physical activity, or sxs at rest
How is BNP related to CrCl?
BNP is renally excreted, so it is inversely proportional to Cr Clearance
How do you interpret BNP levels?
What is the exception?
BNP < 100 excludes HF as cause of dyspnea
BNP > 400 confers 95% likelihood
*exception if BMI > 35 - upper normal is 50 as BNP is possibly cleared by adipocytes
Physio bases for HF treatment: Which meds do you use for the following?
Preload reduction
Diuretics, nitrates
Physio bases for HF treatment: Which meds do you use for the following?
Afterload reduction
ACE/ARB, hydralazine, nitrates
Physio bases for HF treatment: Which meds do you use for the following?
Sympathetic blockade
Beta blockers
Physio bases for HF treatment: Which meds do you use for the following?
Aldosterone antagonist therapy
spironolactone, eplerenone
State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:
ACE/ARB
Reduces morbidity and mortality
LOE A
State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:
Beta blocker
Mortality rates improve with BB in addition to ACEi and diuretics
Decrease mortality in pts with prior MI regardless of NYHA
Start when pt is stable and euvolemic
Which beta blockers are “the proven 3” in HF
Metoprolol succinate, carvedilol, bisoprolol
State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:
Aldosterone antagonists
reduce mortality and improve EF
- GFR must be > 30 and K < 5
- choices are spironolactone and eplerenone
- eplerenon is better for breast tenderness
State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:
Furosemide
Improves symptoms and reduces hospitalizations
Class I recommendation, LOE C
State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:
BIDIL
Hydralazine + Isosorbide Dinitrate
Reduces mortality rates and improves quality of life measures
- particularly effective in african americans with NYHA III or IV HF
- used when diuretics, BB and ACE do not control sx or are not tolerated
State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:
ARNI = ARB + Neprilysin Inhibitor
Compared to enalapril - reduced death and hospitalization
Class I recommendation: use in pts with chronic SYMPTOMATIC HFrEF NYHA II or III
- wait 36 hours after stopping ACEi to start entresto